Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2024 Earnings Call Transcript August 13, 2024
Marinus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.62786 EPS, expectations were $-0.59.
Operator: Greetings and welcome to Marinus Pharmaceuticals’ Second Quarter Financial Results and Business Update Call. [Operator Instructions] It is my pleasure to introduce your host, Sonya Weigle, Chief People and Investor Relations Officer. You may now begin, Ms. Weigle.
Sonya...
